PHARMAIDS PHARMACEUTICALS LTD.
PHARMAID (BSE 524572) · ISIN INE117D01018 · Pharmaceuticals · Est. 1989 · listed 1994 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹53.38 cr | ₹20.45 cr | ₹83.96 cr |
| 30 Sep 2025 standalone | ₹57.78 cr | ₹18.17 cr | ₹97.23 cr |
| 31 Mar 2025 standalone | ₹63.79 cr | ₹39.4 cr | ₹118.69 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 32.99% | — | — | 67.01% |
Latest filings
- Voting Results along with the Scrutinizer''s Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM. 15 September 2026 · BSE
- Outcome of the 37th Annual General Meeting of the Company held on September 11, 2026 i.e., today at 12 noon through VC/OAVM. 11 September 2026 · BSE
- Annual Report FY2025-26 (New) 18 August 2026 · BSE
- Notice of 37th AGM and Annual Report 18 August 2026 · BSE
- Submission of unaudited financial results 12 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.